Showing 181 - 200 results of 1,143 for search '"kidney disease"', query time: 0.08s Refine Results
  1. 181

    Kynurenines and aerobic exercise capacity in chronic kidney disease: A cross-sectional and longitudinal study. by Helena Wallin, Eva Jansson, Sophie Erhardt, Carin Wallquist, Britta Hylander, Stefan H Jacobson, Kenneth Caidahl, Anette Rickenlund, Maria J Eriksson

    Published 2025-01-01
    “…<h4>Background</h4>The causes of reduced aerobic exercise capacity (ExCap) in chronic kidney disease (CKD) are multifactorial, possibly involving the accumulation of tryptophan (TRP) metabolites such as kynurenine (KYN) and kynurenic acid (KYNA), known as kynurenines. …”
    Get full text
    Article
  2. 182

    Projecting the Burden of Chronic Kidney Disease in a Developed Country and Its Implications on Public Health by L. Y. Wong, A. S. T. Liew, W. T. Weng, C. K. Lim, A. Vathsala, M. P. H. S. Toh

    Published 2018-01-01
    “…Background. Chronic Kidney Disease (CKD) is a major public health problem worldwide. …”
    Get full text
    Article
  3. 183

    Prevalence and Management Recommendations for Disease-Related Malnutrition in Chronic Kidney Disease Patients with and without Diabetes by Li-Li Dai, Wei-Li Li, Ding-Feng Zheng, Wei-Hong Wang, Hao-Fen Xie, Jian-Wei Ma

    Published 2022-01-01
    “…To investigate the nutritional risk, malnutrition, severe malnutrition, and malnutrition prevalence of different stages in chronic kidney disease (CKD) patients with and without diabetes mellitus using the Global Leadership Initiative on Malnutrition (GLIM), and to analyze the causes of malnutrition and to improve the clinical outcomes of patients for early intervention. …”
    Get full text
    Article
  4. 184
  5. 185

    The Enormity of Chronic Kidney Disease in Nigeria: The Situation in a Teaching Hospital in South-East Nigeria by Ifeoma I. Ulasi, Chinwuba K. Ijoma

    Published 2010-01-01
    “…The magnitude of the problem of chronic kidney disease (CKD) is enormous, and the prevalence keeps rising. …”
    Get full text
    Article
  6. 186
  7. 187
  8. 188
  9. 189

    Predicting the onset of chronic kidney disease (CKD) for diabetic patients with aggregated longitudinal EMR data. by Neda Aminnejad, Michelle Greiver, Huaxiong Huang

    Published 2025-01-01
    “…Chronic kidney disease (CKD) affects over 13% of the population, totaling more than 800 million individuals worldwide. …”
    Get full text
    Article
  10. 190

    A Study on the Application of Explainable AI on Ensemble Models for Predictive Analysis of Chronic Kidney Disease by K. M. Tawsik Jawad, Anusha Verma, Fathi Amsaad, Lamia Ashraf

    Published 2025-01-01
    “…Chronic Kidney Disease (CKD) is one of the widespread Chronic diseases with no known ultimo cure and high morbidity. …”
    Get full text
    Article
  11. 191
  12. 192
  13. 193
  14. 194

    The Emerging Role of Implementing Machine Learning in Food Recommendation for Chronic Kidney Diseases Using Correlation Analysis by Sachin Gupta, Neeraj Garg, Divyanshu Sinha, Babita Yadav, Bhoomi Gupta, Shahajan Miah

    Published 2022-01-01
    “…The present research relates to the use of ML in proper kidney disease diagnosis and food recommendations for treatment accordingly. …”
    Get full text
    Article
  15. 195

    Effects of Tocotrienol on Cardiovascular Risk Markers in Patients With Chronic Kidney Disease: A Randomized Controlled Trial by Liana Trugilho, Lívia Alvarenga, Ludmila Cardozo, Bruna Paiva, Jessyca Brito, Isis Barboza, Jonatas Almeida, Juliana dos Anjos, Pramod Khosla, Marcelo Ribeiro-Alves, Denise Mafra

    Published 2025-01-01
    “…Tocotrienols, isomers of vitamin E, may provide an effective nutritional strategy to mitigate common cardiovascular risks such as dyslipidemia, inflammation, and oxidative stress in patients with chronic kidney disease (CKD). This double-blind, placebo-controlled, randomized clinical trial aimed to evaluate the effects of a tocotrienol-rich fraction (TRF) supplementation (300 mg/day) on oxidative stress and inflammatory markers, including transcription factors in nondialysis (ND) and hemodialysis (HD) CKD patients for three months. …”
    Get full text
    Article
  16. 196
  17. 197
  18. 198
  19. 199
  20. 200